![](/images/general/no_picture/200_user.png)
Hai V Tran
Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )
Most Active Art Unit | 2845 |
Art Unit(s) | 2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821 |
Total Applications | 1291 |
Issued Applications | 923 |
Pending Applications | 111 |
Abandoned Applications | 257 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14497923
[patent_doc_number] => 20190192616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
[patent_app_type] => utility
[patent_app_number] => 16/291915
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16291915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/291915 | Vasopressin formulations for use in treatment of hypotension | Mar 3, 2019 | Issued |
Array
(
[id] => 18389888
[patent_doc_number] => 20230158106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => COMPOSITION FOR PREVENTING, RELIEVING OR TREATING CARTILAGE-RELATED DISEASES OR SYMPTOMS, COMPRISING HAPLN1
[patent_app_type] => utility
[patent_app_number] => 17/297707
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297707 | COMPOSITION FOR PREVENTING, RELIEVING OR TREATING CARTILAGE-RELATED DISEASES OR SYMPTOMS, COMPRISING HAPLN1 | Feb 27, 2019 | Pending |
Array
(
[id] => 15405523
[patent_doc_number] => 20200023083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/288655
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/288655 | METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES | Feb 27, 2019 | Abandoned |
Array
(
[id] => 18901460
[patent_doc_number] => 20240016945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOSITION AND METHOD FOR NEW ANTIMICROBIAL AGENTS WITH SECONDARY MODE OF ACTION PROVIDED BY CONJUGATION OF AN ANTIMICROBIAL TO A GUANIDINIUM-RICH MOLECULAR TRANSPORTER
[patent_app_type] => utility
[patent_app_number] => 16/968834
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968834
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968834 | COMPOSITION AND METHOD FOR NEW ANTIMICROBIAL AGENTS WITH SECONDARY MODE OF ACTION PROVIDED BY CONJUGATION OF AN ANTIMICROBIAL TO A GUANIDINIUM-RICH MOLECULAR TRANSPORTER | Feb 20, 2019 | Pending |
Array
(
[id] => 14893903
[patent_doc_number] => 20190290717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE AND/OR INJURY
[patent_app_type] => utility
[patent_app_number] => 16/279621
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279621
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279621 | Compositions and methods for treating heart disease and/or injury | Feb 18, 2019 | Issued |
Array
(
[id] => 17134817
[patent_doc_number] => 11136363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Compositions and methods for diagnosing and/or treating kidney injury
[patent_app_type] => utility
[patent_app_number] => 16/265413
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 26
[patent_no_of_words] => 64292
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265413 | Compositions and methods for diagnosing and/or treating kidney injury | Jan 31, 2019 | Issued |
Array
(
[id] => 18575502
[patent_doc_number] => 11732016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Polypeptide exhibiting granulocyte-colony stimulating factor activity
[patent_app_type] => utility
[patent_app_number] => 16/957281
[patent_app_country] => US
[patent_app_date] => 2018-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 7555
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957281
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957281 | Polypeptide exhibiting granulocyte-colony stimulating factor activity | Dec 23, 2018 | Issued |
Array
(
[id] => 14216931
[patent_doc_number] => 20190120850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => DETERMINATION OF PROTEIN AGGREGATION FROM THE CONCENTRATION DEPENDENCE OF DELTA G
[patent_app_type] => utility
[patent_app_number] => 16/227031
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227031
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/227031 | DETERMINATION OF PROTEIN AGGREGATION FROM THE CONCENTRATION DEPENDENCE OF DELTA G | Dec 19, 2018 | Abandoned |
Array
(
[id] => 17625822
[patent_doc_number] => 20220160837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => LIQUID PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/768351
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768351
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768351 | Liquid pharmaceutical composition | Dec 19, 2018 | Issued |
Array
(
[id] => 17905548
[patent_doc_number] => 11459392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Anti-CD70 antibody drug conjugates
[patent_app_type] => utility
[patent_app_number] => 16/224346
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 68770
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 750
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224346
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224346 | Anti-CD70 antibody drug conjugates | Dec 17, 2018 | Issued |
Array
(
[id] => 16072309
[patent_doc_number] => 20200190141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PEPTIDE FOR INHIBITING SKIN INFLAMMATION AND COMPOSITION FOR PREVENTING OR TREATING SKIN INFLAMMATION CONTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/346861
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346861 | Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the same | Dec 16, 2018 | Issued |
Array
(
[id] => 18837746
[patent_doc_number] => 11845809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Maleate of SCY-635 and uses thereof in medicine
[patent_app_type] => utility
[patent_app_number] => 17/413054
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 5610
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413054
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413054 | Maleate of SCY-635 and uses thereof in medicine | Dec 13, 2018 | Issued |
Array
(
[id] => 16899065
[patent_doc_number] => 20210177981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => CONJUGATE BASED SYSTEMS FOR CONTROLLED INSULIN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/771819
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771819
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771819 | Conjugate based systems for controlled insulin delivery | Dec 12, 2018 | Issued |
Array
(
[id] => 14130075
[patent_doc_number] => 20190099427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME
[patent_app_type] => utility
[patent_app_number] => 16/217421
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16217421
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/217421 | USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME | Dec 11, 2018 | Abandoned |
Array
(
[id] => 17712324
[patent_doc_number] => 11376303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Compositions and methods for treating nervous system injuries
[patent_app_type] => utility
[patent_app_number] => 16/770041
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 22834
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770041
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770041 | Compositions and methods for treating nervous system injuries | Dec 5, 2018 | Issued |
Array
(
[id] => 14099217
[patent_doc_number] => 20190091284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation
[patent_app_type] => utility
[patent_app_number] => 16/211757
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211757
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/211757 | Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation | Dec 5, 2018 | Abandoned |
Array
(
[id] => 14684991
[patent_doc_number] => 20190241610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => SYNTHETIC PEPTIDE AMIDES
[patent_app_type] => utility
[patent_app_number] => 16/199308
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16199308
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/199308 | Synthetic peptide amides | Nov 25, 2018 | Issued |
Array
(
[id] => 17996700
[patent_doc_number] => 11497786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Stable ascorbic acid compositions and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/764781
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 24285
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764781 | Stable ascorbic acid compositions and methods of using the same | Nov 15, 2018 | Issued |
Array
(
[id] => 17904356
[patent_doc_number] => 11458189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Cytoprotective drugs
[patent_app_type] => utility
[patent_app_number] => 16/764618
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 13362
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764618 | Cytoprotective drugs | Nov 15, 2018 | Issued |
Array
(
[id] => 17392514
[patent_doc_number] => 11241502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Stable compositions of pegylated carfilzomib compounds
[patent_app_type] => utility
[patent_app_number] => 16/192469
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 24272
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16192469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/192469 | Stable compositions of pegylated carfilzomib compounds | Nov 14, 2018 | Issued |